Atlas Trials

Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma

Clinical trial NCT01310868 · COMPLETED

Trial details

NCT number
NCT01310868
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2011-05-01
Primary completion
2015-03-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.